We’re excited to share the latest updates included in Glooko Web 25.4 and Glooko Mobile 6.14, which are designed to help healthcare providers and care teams move faster with easier-to-understand risk insights, while also making it easier for people living with diabetes to connect devices and apps and remotely share data with their care teams.

Enhancements to the Glooko Clinic Dashboard

The Glooko clinic dashboard, designed to improve diabetes population health management and available in select countries, now features enhanced usability and accuracy improvements, making risk insights clearer for faster action across clinics, hospitals, and health systems.

Other enhancements to our population health tool include:

• Clearer risk visibility: An updated Time in Range layout makes low and very low glucose risk easier to identify at a glance.
• Smarter patient ranking: Patients with diabetes are prioritized by risk category, then by severity of the triggering metric.
• More precise metrics: Risk indicators are displayed with greater precision for clearer comparison and trend tracking.

More Efficient Patient Review in the Glooko Web App

The patient list in the Glooko Web App for healthcare providers has been enhanced to support faster, more efficient workflows and smoother navigation.

Care teams can now see more patient data at once with a wider default view that reduces horizontal scrolling, sort patients better with improved cues that make patient order easier to understand, and see key context through a revised header that stays visible as they scroll through the list.

Streamlined Clinical Workflows with Full Glooko Access in Epic

Healthcare providers using Patient Portal for Professionals can now access the full Glooko Web App directly within the Epic EHR system using SSO via SMaRT on FHIR, reducing platform switching and streamlining daily workflows.

Some of the benefits of this helpful enhancement include launching our diabetes management platform without leaving the EHR or logging in again, the use of core features including the clinic dashboard, patient list, and device assignment within Epic, faster review and action using key patient diabetes data, and reduced clinician burnout from not context switching.

If your clinic is interested in this feature, please email [email protected].

Simplified Device and App Management for People with Diabetes

Managing diabetes and health monitoring devices and apps is now quicker and intuitive in the Glooko Mobile App.

Our newly enhanced search and smarter filtering, better device categorization, and refreshed visuals, including logos, make it easier for people with diabetes to find and connect their devices and apps with fewer clicks. The update also features shortcuts to speed up Glooko’s seamless integration with more than 200 compatible diabetes and health monitoring devices and apps. Once connected, patient data can be securely shared remotely with care teams who can make more informed treatment decisions.

More Information on the Latest Glooko Release

To learn more about these updates, check out the full release notes on our Support Center or reach out to your dedicated Glooko Customer Success Manager.

Every year, the American Diabetes Association (ADA) updates its Standards of Care in Diabetes, the clinical foundation that guides how we screen, diagnose, manage, and support people living with diabetes. The 2026 guidelines are among the most comprehensive to date, with a clear message: diabetes care must evolve to meet rising complexity, widening gaps in care, and the growing urgency to improve outcomes across entire populations.

This year’s recommendations underscore that our work in connected care has never been more important.

Population health requires stronger systems, better data, and integrated teams

The Standards highlight that population health is not simply a measurement framework, but rather a commitment to improving outcomes for groups of people who experience very different barriers, risks, and trajectories. The ADA emphasizes team-based, patient-specific care, timely treatment decisions, reliable data metrics to track quality, and a culture of continuous improvement across health systems.

These priorities mirror what clinicians experience every day: fragmented systems, variable follow-up, and the challenge of navigating high-risk patients without the right tools or insights. Platforms like Glooko, which provide timely insights, structured data access, clinical integration directly into the EHR, and simplified workflows, play a direct role in enabling the proactive care models the ADA calls for. When healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. This is critical in providing insights into metabolic factors and indications of clinical risk to facilitate shared decision making conversations in a personalized way, with patients and their support systems.This patient-centric approach helps healthcare providers–including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics–provide individualized care recommendations that are patient-specific.

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. By centralizing population-level metrics, care teams can more quickly identify disengaged patients, prioritize outreach, and intervene earlier, supporting both quality goals and clinic efficiency.

Glycemic management is becoming more nuanced and more actionable

The 2026 Standards reinforce the importance of individualized glycemic assessment. A1C remains central, but ADA again stresses the clinical value of time in range (TIR), time below range (TBR), and continuous glucose monitoring (CGM) metrics for real-time, person-centered care. We observed similar trends in our 2025 Annual Diabetes Report.

For many clinicians, the challenge is not whether to use CGMs, it’s how to interpret data efficiently and translate trends into action. This is where connected, device-agnostic platforms are essential. Having glucose data delivered in clinically meaningful formats, integrated with insulin dosing, meals, and activity, allows teams to identify risks earlier, adjust therapy faster, and support patients between visits.

This is especially critical for populations highlighted in the Standards: individuals facing food or housing insecurity, young adults with rising complication rates, rural communities with limited access, and older adults with shifting needs. Digital tools do not replace clinicians; they expand their reach.

Inpatient glycemic safety: Operationalizing the ADA’s call for safer insulin use

The 2026 Standards dedicate significant space to preventing hypoglycemia, hyperglycemia, and hyperglycemic crises, events that disproportionately impact people with diabetes during hospitalization or acute illness. ADA guidance reinforces the need for:

• Structured insulin protocols
• Frequent monitoring to adjust dosing
• Systems that minimize variation in clinical decision-making
• Approaches that reduce risk during periods of physiologic instability

This is exactly where EndoTool, developed by Monarch Medical Technologies, a Glooko Company, plays a transformative role. EndoTool brings advanced, patient-specific insulin dosing to inpatient settings, enabling dynamic adjustments based on each patient’s evolving physiology. By reducing glycemic variability and supporting timely identification of trends, EndoTool aligns directly with ADA recommendations around individualized glycemic targets, hypoglycemia prevention, and safer transitions of care.

As health systems work to connect inpatient and outpatient data streams, as the Standards increasingly encourage, EndoTool and Glooko have the potential to create a more actionable ecosystem. Patients leave the hospital with a more stable glycemic trajectory, and outpatient teams gain a clearer picture of what occurred during admission, supporting smoother recovery and reduced readmissions.

A vision aligned with where diabetes care is going

Across all 2026 recommendations, a single theme stands out: better outcomes depend on proactive, connected, team-based, data-driven care. The Standards call for more timely therapy changes, broader Diabetes Self-Management Education and Support (DSMES) access, stronger telehealth offerings, and improved system-level accountability.

At Glooko, we’re proud to support clinicians and health systems in delivering on those goals by making diabetes data easier to use, helping teams coordinate more effectively, and empowering people with diabetes with insights that fit their daily lives.

The work ahead is significant, but the path is clearer than ever. Together, we can turn these standards into sustained, measurable improvements in the health of patients and the clinician experience.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

Last month, I had the opportunity to attend the IHI Forum, an annual conference that brings together passionate healthcare professionals interested in advancing quality improvement, patient safety, and closing care gaps together. I was inspired by the many ideas shared during keynotes, sessions, and workshops tied to the theme of transforming healthcare by increasing safety, reducing complication severity, and improving sustainability.

My biggest takeaway: the conversation around ROI in healthcare is shifting toward acknowledging that the strongest ROI comes from prioritizing safety and outcomes. When care is safer and complications are reduced, cost savings naturally follow.

The many insights made me think about how digital health technologies, like the Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, can create real, measurable value for hospitals and health systems.

Implementing Digital Solutions to Reduce Costs and Clinical Overhead

To achieve meaningful financial impact, healthcare organizations can map value streams directly to clinical outcomes, an effort that has become very common across the healthcare industry. By improving patient outcomes and reducing the incidence and severity of glycemic events through timely intervention, healthcare providers can shift their focus toward cost avoidance.

This cost-cutting effort is primarily achieved by reducing the frequency of high-cost events like diabetic ketoacidosis (DKA) or severe hypoglycemia, both proven to be reduced through use of the EndoTool inpatient platform, and mitigating the severity of complications. These improvements not only protect patient health, but also significantly lower the financial burden associated with emergency hospitalizations.

From an operational perspective, broader adoption of digital health solutions that integrate seamlessly into EHR systems, like Glooko and EndoTool, drive revenue by minimizing administrative burden and eliminating the physical costs of traditional paper-based documentation. This transition supports a smaller carbon footprint while streamlining Diagnostic Related Group (DRG) cost structures. By automating data entry and refining monitoring systems, hospitals can reduce manual labor hours, alleviate the hidden costs of alarm fatigue, and successfully decrease the average Length of Stay (LOS) for patients.

Advancing Innovation for Better Health Outcomes

In the landscape of modern healthcare rankings, the severity of patient complications has become a defining metric, often accounting for a significant portion of the evaluation of hospitals in reports like U.S. News & World Report’s annual Best Hospital rankings.

To address this, healthcare providers must look beyond basic data collection and focus on innovative digital health tools that actively mitigate these risks. For example, hospital readmissions could be reduced when healthcare providers are issued remote monitoring alerts based on trends in a patient’s health. Doctors may also shorten hospital stays if they have the ability to remotely monitor vitals.

By integrating capabilities like remote monitoring in the Glooko diabetes management platform, clinics can demonstrate a measurable reduction in the severity of outcomes, providing a safer patient experience while potentially strengthening their standing in critical industry benchmarks, including the CMS Overall Hospital Quality Star Rating and Newsweek’s “America’s Best-In-State Hospitals.”

Real impact starts with a deep dive into existing workflows to find and fix hidden gaps in diabetes care. Care teams can map out the root causes of care gaps and pinpoint exactly where digital solutions can bridge them. For instance, Glooko’s acquisition of Monarch Medical Technologies will help bridge the gap between inpatient glycemic management and outpatient diabetes care in the future. This future state, advancing continuity of care, can create a more unified ecosystem that manages diabetes holistically and helps ensure no patients feel isolated in their journey.

Improving the Patient, Family, and Staff Experience

To define success beyond traditional clinical metrics, the focus of ROI must shift toward the holistic quality of life for patients in the hospital or at home and their families.

Our solutions aim to improve the patient experience by shortening hospital stays and fostering a more restorative healing environment. By proactively managing glycemic health and reducing the severity of acute events, we allow patients and their caregivers to focus on recovery and living their life day-to-day rather than the stress of a potential health crisis.

We truly believe clinicians should spend more time with patients and less time with paperwork. That’s why we’ve designed our glycemic and diabetes management solutions with the care teams in mind. By automating data flows and simplifying complex glycemic management, we remove the “manual logistics” and heavy cognitive load that lead to burnout and reduce patient safety.

This efficiency doesn’t just improve the bottom line but could help prevent expensive complications like DKA and severe glycemic events. It creates a sustainable work environment where care teams feel empowered to provide high-value, compassionate care without being tethered to a screen.

Furthering Sustainable Practices through EHR Integrations

Sustainability and person-centered care are inseparable as it is critical we focus on the holistic well-being of the patient and their community.

Sustainability has transitioned from an elective corporate responsibility to a core operational mandate for healthcare executives. For leadership, prioritizing sustainable practices is not just about environmental stewardship. It is a strategic lever for improving patient outcomes, ensuring long-term financial viability and fulfilling the mission of “first, do no harm.”

By digitizing workflows and leveraging built-in EHR integrations, hospitals and clinics can move away from paper-heavy documentation, significantly reducing paper waste and recycling expenses. This transition doesn’t just lower operational costs as it also shrinks the carbon footprint of the practice, aligning financial savings with environmental sustainability.

Glooko and EndoTool help healthcare providers slash overheads by eliminating the physical and environmental burdens of traditional diabetes management through the solutions’ EHR integrations, future-proofing sustainability efforts.

Ready for a Glimpse into the Cost-Efficient Future of Diabetes Care?

Connect with a Glooko rep today to learn how our diabetes and glycemic management solutions can help reduce your costs, while improving health outcomes.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

As 2025 comes to a close, it is clear that this has been a defining year for Glooko and for the broader evolution of diabetes care. Following the close of our Series F, we entered the year with a clear focus: deliver on our strategy, expand our global impact, and continue building technology that helps make diabetes care more connected, actionable, and human.

Accelerating our Mission through Strategic Leadership and a Connected Care Continuum

Over the past year, we reached several important milestones in support of that goal. We expanded our capabilities through the acquisition of Monarch Medical Technologies and its EndoTool Glucose Management System, bringing together complementary capabilities across outpatient and inpatient diabetes and glycemic management.

We strengthened our ecosystem with the launch of our Abbott FreeStyle Libre integration in the U.S., helping ensure that critical glucose data can flow more seamlessly to people with diabetes and their care teams.

We also reinforced our clinical leadership with the appointment of Mark Clements, M.D., Ph.D., as Chief Medical and Strategy Officer, underscoring our commitment to evidence-based innovation and strong clinical partnership.

Driving Digital Health Adoption in EMEA

We also saw meaningful traction across geographies and care settings.

In EMEA, we continued to expand our presence as health systems look for scalable, interoperable digital solutions to support diabetes care. At the same time, Glooko XT, our remote monitoring solution available only in France, introduced new features and strengthened its gestational diabetes management capability, an area where timely insights and coordinated care are critical for both maternal and fetal outcomes. These areas of momentum reflect the growing demand for digital tools that can support diverse patient populations and clinical workflows.

Further Enhancing our Diabetes Management Platform to Improve Care

On the product front, we continued to invest in tools designed for the realities of care delivery.

The launch of the new Glooko clinic dashboard marked an important step forward in helping clinics and health systems move beyond raw data to clearer insights, enabling more informed, timely decisions at the point of care. Across the organization, we remained focused on bringing teams together around a shared mission and shared standards, ensuring that our growth continues to be purposeful and aligned.

A reality faced by care teams each day is the need for timely, actionable data within existing clinical workflows. That’s why we invested further into our EHR capabilities this year and joined the Epic Showroom to make it easier for hospitals and health systems to seamlessly integrate their EHR with Glooko, helping reduce clinician burnout and optimize clinical workflows.

The Glooko Mobile App for people with diabetes also continued to innovate in 2025 with a redesigned food tracker for more insightful nutrition data and insights, revised insulin cards for more clarity, and viewable GLP-1 doses. These enhancements enable care teams to make more informed and timely treatment decisions between appointments using their patients’ health data – all viewable in one place.

How the U.S. Healthcare System is Moving Toward Data-Driven, Accountable Diabetes Care

These milestones matter, but they are occurring against a broader backdrop of change in healthcare that strongly validates this direction. The latest American Diabetes Association’s Standards of Care reinforce what clinicians and people with diabetes have long understood: technology-enabled management and data-driven insights are now foundational to delivering high-quality diabetes care.

At the same time, policy initiatives such as the CMS ACCESS program signal a growing emphasis on interoperability, data liquidity, and the responsible use of health data to improve outcomes at scale.

Together, these shifts point to a future in which diabetes care is increasingly proactive rather than reactive, and where data is not simply collected, but translated into meaningful action.

Regulatory momentum is reinforcing the importance of consistent, evidence-based glycemic management across care settings. CMS’s upcoming electronic clinical quality measure (eCQM) requirements for inpatient glycemic management, expected to take effect in 2026, reflect a growing emphasis on standardization, measurement, and accountability in hospital-based diabetes care. Solutions like EndoTool are at the forefront of this shift, helping health systems operationalize best practices, support clinical decision-making, and drive more reliable glycemic outcomes at scale.

For healthcare providers and care teams, this evolution brings both opportunity and urgency. As care becomes more continuous and data-rich, success depends on having tools, like Glooko’s EHR integrations, that reduce complexity, surface what matters most, and fit naturally into clinical workflows. The goal is not more data for its own sake, but clearer insight that supports better decisions and more personalized care.

For health systems, the focus is expanding to population-level impact. Managing chronic disease across diverse populations requires platforms that enable earlier intervention, more consistent care, and coordination across settings. Interoperable digital solutions, like Glooko, are becoming essential infrastructure for balancing quality, efficiency, and cost in an increasingly complex care environment.

Leveraging Scalable Healthcare Technology to Deliver Consistent Diabetes Care Around the World

Globally, the stakes are even higher. Diabetes prevalence continues to rise across regions with very different healthcare resources and delivery models. Scalable digital health solutions offer a path to extend evidence-based care, support clinicians, and bring greater consistency to diabetes management worldwide. As global standards and policies evolve, technology will play a central role in enabling more equitable access to high-quality care.

The Road Ahead for Glooko

Looking ahead, our focus at Glooko remains clear. We will continue investing in platforms that turn diabetes data into insight, insight into action, and action into better outcomes. We will deepen partnerships across the ecosystem and stay closely aligned with clinicians, health systems, and people with diabetes as their needs continue to evolve.

2025 was a year of momentum for Glooko. More importantly, it reinforced why our mission matters. As the future of diabetes care continues to take shape, we are energized by the opportunity to help lead the way.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

Healthcare providers struggle to manage large diabetes populations without a comprehensive view of patient data.

During this webinar, Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, and Glooko Senior Clinical Transformation Director Trisha Martinez, BSN, MBA, RN, explore the new Glooko clinic dashboard, a powerful tool designed to streamline diabetes population health management and enable smarter care across hospitals, health systems, and clinics.

Our clinical experts take a deep dive into this user-friendly dashboard, available in select countries, and showcase its at-a-glance insights into patient trends and key clinic metrics that can help care teams easily interpret complex data for more efficient decision-making.

Ready to optimize diabetes population health management?

Contact Team Glooko for a demo of our new clinic dashboard, which helps healthcare teams manage large diabetes populations more effectively by prioritizing care and boosting patient engagement.

MKT-0468

During this Glooko 101 webinar, Glooko Senior Director of Clinical Transformation Trisha Martinez, BSN, MBA, RN, helps healthcare providers, including endocrinologists, nurses, and certified diabetes care and education specialists, get the most out of their professional Glooko account, reviewing core features and tools that support clinical workflows for both new users and those looking for a refresher.

This session also covers best practices for onboarding patients with diabetes using continuous glucose monitors (CGMs), including how to connect CGM data to Glooko to ensure seamless access to glucose trends and actionable insights from day one.

Time to Optimize your Diabetes Practice

Book a one-on-one session with Team Glooko today to better understand how to optimize Glooko from the start, get customized guidance on connecting CGM data, and gain access to actionable glucose trends care teams need.

MKT-0473

The role of certified diabetes care and education specialists (CDCESs) is vital in helping people with diabetes manage their condition, achieve optimal health outcomes, and thrive.

Glooko’s innovative web platform and mobile app is designed to make diabetes care and education more efficient, data-driven, and impactful for these critical care team members.

By providing cutting-edge capabilities, Glooko empowers CDCESs at hospitals, health systems, and clinics to support patients’ diabetes management, reduce the risk of complications, and improve health outcomes.

Advantages of CDCESs Leveraging Glooko

Glooko offers a range of features in its platform that streamlines clinical workflows, enhances the decision-making for CDCES professionals and the entire diabetes care team, and ultimately, supports better diabetes management and care:

• Expansive Device Compatibility: Glooko seamlessly integrates with over 200 diabetes and health monitoring devices and apps, centralizing relevant health data and making it easily accessible.
• Clinic Dashboard for Diabetes Population Health Management: Our new clinic dashboard, available in select countries, provides CDCESs with at-a-glance insights of a clinic’s diabetes patient population, leading to more efficient, data-driven decisions.
• Seamless EHR Integrations: Our integrations with leading electronic health records (EHRs), including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, securely centralizes diabetes and related health data, giving CDCESs a complete view of a patient’s health in one place and eliminating the hassle of platform switching and multiple logins.
• Educational Digital Care Programs: Glooko’s care programs complement the work of the CDCES by providing patients with structured education that advances their understanding of diabetes management.
• Easier Log-in with SSO: Single Sign-On (SSO) eliminates the need for multiple logins and passwords, cutting credential hassle so CDCESs can focus more time on delivering high-quality patient care.
• Exceptional Customer Support: Backed by rapid response times, an extensive help center, and U.S.-based support, CDCESs can spend less time troubleshooting technical issues and more time focused on their patients.

Glooko Advances the ADCES7 Self-Care Behaviors®

Diabetes Self-Management Education and Support (DSMES) is a program from the Association of Diabetes Care and Education Specialists (ADCES) designed to empower individuals with diabetes to manage their condition effectively. It’s structured around the ADCES7 Self-Care Behaviors, which represent seven critical areas of diabetes self-management.

CDCES professionals partner with patients with diabetes to help prioritize and improve their own management skills across these seven essential behaviors. CDCESs can leverage the Glooko Mobile App, which supports patients in tracking and managing each of these behaviors, to complement their own education and guidance:

• Healthy Eating: People living with diabetes can enter food into the Glooko Mobile App to better understand how nutrition affects their condition and well-being.
• Being Active: The app allows tracking of steps, fitness, and other exercises, helping users understand the impact of physical activity on their overall health and glycemic control.
• Taking Medication: Patients can track medication, set reminders, and enter notes about the impact of medications, which can be shared with care teams.
• Reducing Risk: Through its manual entry feature and compatibility with smart scales and blood pressure cuffs, the Glooko Mobile App can be used to monitor trends in weight and blood pressure.
• Problem Solving: The app helps users identify patterns in everything from nutrition and weight to insulin and glucose levels and solve challenges independently or through remote collaboration with their car team.
• Healthy Coping: People with diabetes can record notes in the Glooko Mobile App about their feelings, beliefs, challenges, and successes while managing their diabetes.

Users of the Glooko Mobile App also can access our comprehensive support center for troubleshooting and helpful tips, allowing them to make the most of the app’s features.

Enhance the CDCES-Patient Experience with Glooko

At Glooko, we provide CDCES professionals with digital health tools for simpler diabetes management and better health outcomes for their patients.

Find out how Glooko’s diabetes management software can support your care team’s delivery of data-driven, high-quality care by scheduling a demo.

October is Cybersecurity Awareness Month, but for Glooko, the only diabetes management company with multiple industry-leading security certifications, our commitment to protecting patient health data is a year-round mission.

According to Glooko CEO Mike Alvarez, one of our diabetes management company’s core differentiators is our commitment to patient safety and data privacy, which enables us to build and maintain trust with hospitals, health systems, clinics, and people living with diabetes.

As the healthcare industry faces rising cyberattacks, Glooko understands that securing health data and ensuring the security and privacy of this sensitive information is not just a policy — it’s a core responsibility.

Building a Foundation of Trust Through Security Certifications

Security isn’t a single feature you can switch on; it’s a comprehensive framework built on continuous commitment, sophisticated technology, and rigorous auditing.

As the most secure diabetes management platform, Glooko has invested heavily in achieving and maintaining a number of rigorous global security certifications and standards, which serve as a powerful testament to the maturity and diligence of our security practices that safeguard the sensitive personal and health data of our users with diabetes.

Here are the key standards and certifications that build Glooko’s security backbone:

• ISO 27001: This globally recognized information security management standard outlines requirements for an information security management system (ISMS). Achieving this certification means an organization has a systematic approach to managing sensitive company and customer information.
• SOC 2 Type II and SOC 3 Certification: These internationally recognized global reporting standards, validated by an auditing firm, verify that Glooko’s controls across its employees, systems, and processes fully secure all customer data, software, and company assets.
• HITRUST Risk-based, 2-year (r2) Certification: Achieving this healthcare industry gold standard confirms our stringent, independently-audited security controls meet the highest requirements of frameworks like HIPAA and NIST. This places us in an elite group dedicated to protecting sensitive patient health data. Explore our recent study on strengthening our cyber resilience…
• HIPAA Compliance: This U.S. federal law ensures the protection of sensitive patient health information from being disclosed without the patient’s consent or knowledge.
• The NHS Digital Data Security and Protection Toolkit (DSPT): For operations in the U.K., this framework ensures that patient data is handled securely and in a way that respects privacy.
• GDPR: This comprehensive European Union law gives individuals control over their personal data by setting strict rules for how organizations worldwide must collect, process, and protect that information.

How Diabetes Patient Health Data is Protected on a Day-to-Day Basis

Beyond the certifications, hundreds of controls are implemented to ensure data remains secure at Glooko. Our approach, covering protection, defense, response, and recovery, includes:

• Continuous Vulnerability Management: Regular penetration testing and vulnerability scans are conducted to proactively identify and address potential weaknesses in their systems.
• Internal Governance: A dedicated governance board oversees our diabetes management company’s policies, ensuring that security and privacy are considered in all decisions.
• Employee Training: A core element of any security strategy is the people. Team Glooko receives regular, mandatory training on data security and privacy protocols.
• Privileged Access Management: Policies are in place to ensure that only authorized personnel have access to sensitive information.
• Secure Software Development Lifestyle (SSDLC): Security code reviews, threat modeling, and static and dynamic code scans are completed during the software development lifecycle

Your Data, Your Control

A crucial part of data privacy is the user’s right to control their information. We make it clear that personally identifiable data is never shared without explicit consent. When using the platform through a healthcare provider, Glooko functions as a part of the healthcare provider’s operations, always adhering to the same stringent privacy standards.

Our Constant Commitment to Protecting Patient Safety

Cybersecurity Awareness Month is a great starting point, but data protection requires constant, evolving, and year-round efforts because threats are always changing.

Through a combination of robust technical controls, a culture of security, and adherence to global standards, Glooko’s commitment to trust and privacy is a fundamental part of our connected care company beyond October.

When healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. Available in select countries, the dashboard helps healthcare providers, including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics streamline their diabetes population health management.

Developed for busy healthcare professionals, the new Glooko clinic dashboard is based on TIDE (Timely Interventions for Diabetes Excellence) metrics to help address the challenge of managing a large diabetes patient population. This user-friendly view provides at-a-glance insights into patient population trends and key clinic metrics, making it easier for the entire care team to interpret complex data and guide more efficient decision-making and clinic strategy.

Built on TIDE Metrics for Smarter Diabetes Care

Leveraging evidence-based risk identification logic developed by Stanford researchers to further enhance clinical insights, personalize care, and demonstrate scalable, cost-effective outcomes, the TIDE dashboard, which demonstrated in a 2022 study to reduce screen time for healthcare providers reviewing patient data by 86%, is a powerful tool designed to help clinical teams manage large populations of patients with type 1 diabetes.

The TIDE dashboard uses smart algorithms to analyze and remotely monitor data from continuous glucose monitoring (CGM) devices, helping care teams efficiently and effectively manage their patients’ health. Using essential glucose measures like Time in Range and hypoglycemia, the TIDE model also prioritizes which patients need immediate attention by sorting them by clinical risk, so healthcare providers can focus on those who need it most without sifting through every patient’s data individually.

The TIDE model-based Glooko clinic dashboard offers our professional users a user-friendly way to tackle the challenge of managing a large patient population with three intuitive sections.

Understand Patient Population At-A-Glance

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. This space displays the total number of patients with diabetes, identifies who is actively monitoring their blood glucose by blood glucose monitors (BGM) or CGM, and shows which patients have completed their Glooko account registration and are actively syncing their health data remotely with our connected care platform.

By centralizing these metrics, this comprehensive section of the dashboard helps healthcare providers shape clinic strategy more efficiently and better understand which patients to contact to activate their Glooko account to make more informed decisions based on synced health data.

Prioritize Care Based on Key CGM Metrics

The CGM Patient Risk Stratification section of the new Glooko clinic dashboard helps healthcare providers prioritize patient care and gives care teams a streamlined view of their patient population, sorted by clinical risk based on key glucose metrics from CGMs. Care teams can easily spot which patients need attention first. The dashboard ranks patients using indicators like Time in Range, Time Below Range, and other key CGM indicators, so healthcare providers can prioritize outreach and interventions based on the most important CGM data, making it easier for them to focus their time on the patients who need it most.

Boost Patient Engagement and Optimize Care

The Engagement Metrics module of the new Glooko clinic dashboard helps healthcare providers spot engagement gaps in their patient population over the past 90 days.

The Patient Account Status section examines the patient population to see if they’ve set-up their Glooko account based on Activated, Invited Pending, Never Invited, and Likely Duplicates. With these key metrics, care teams can quickly see which patients with diabetes haven’t completed the sync to Glooko with their diabetes and health monitoring devices as well as the activation process, allowing for more efficient follow-up and activation.

In the Sync Methods section, care teams can see how patients with diabetes are syncing their data with Glooko. When more health data is synced with Glooko from the cloud, Glooko Mobile App, Transmitter, or Uploader, care teams can make more informed and timely treatment decisions.

Experience Glooko’s New Clinic Dashboard

Ready to see how the intuitive, new Glooko clinic dashboard can optimize diabetes population health management at your clinic, hospital, or health system? Contact our team for a demo.

Unlock the full potential of the Glooko diabetes management platform in this comprehensive webinar led by Glooko Senior Director of Clinical Transformation Trisha Martinez, BSN, MBA, RN.

From foundational basics to advanced analytics, this session provides new users and seasoned professionals with a deep dive into the tools and features specifically built to enhance the diabetes management and care experience for healthcare providers and their patients with diabetes.

Our clinical expert also demonstrates how to leverage Glooko’s broad device compatibility to bridge data gaps. By transforming disconnected data into actionable insights across an entire patient population, healthcare providers can optimize clinical workflows and deliver elevated, data-driven patient care.

Manage your Diabetes Patient Population with New Depth

Schedule a one-on-one session with Team Glooko today to learn how to turn disconnected diabetes data into meaningful care and improved experiences for patients and healthcare providers.

Looking for more Glooko tips and tricks? Visit our Help Center.

MKT-0546